# Indirect Comparison Between Eltrombopag & Romiplostim

> **NCT01236014** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Thrombocytopaenia

## Interventions

- **DRUG:** Eltrombopag
- **DRUG:** Romiplostim
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01236014
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01236014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01236014, "Indirect Comparison Between Eltrombopag & Romiplostim". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01236014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*